We are live on ! Find out more
COEPW

Coeptis Therapeutics Warrants

Delisted

COEPW was delisted on the 24th of April, 2026.

21 hedge funds and large institutions have $2.82M invested in Coeptis Therapeutics Warrants in 2021 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 2

59% more capital invested

Capital invested by funds: $1.77M → $2.82M (+$1.04M)

24% more funds holding

Funds holding: 1721 (+4)

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

Holders
21
Holders Change
+4
Holders Change %
+23.53%
% of All Funds
0.37%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
2
Reduced
2
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
RCM
1
Radcliffe Capital Management
Pennsylvania
$739K
GCL
2
Glazer Capital LLC
New York
$481K +$454K +891,517 New
Citadel Advisors
3
Citadel Advisors
Florida
$324K -$102 -200 -0%
ICM
4
Ionic Capital Management
New York
$236K
BCM
5
Basso Capital Management
Connecticut
$162K
BFM
6
Boothbay Fund Management
New York
$148K +$7.63K +15,000 New
KC
7
Kepos Capital
New York
$135K +$127K +250,000 New
OCAM
8
Owl Creek Asset Management
New York
$105K
Wells Fargo
9
Wells Fargo
California
$82K
RCM
10
Rivernorth Capital Management
Florida
$81K
AA
11
AQR Arbitrage
Connecticut
$70K
SCM
12
Shaolin Capital Management
Florida
$57K
PC
13
Periscope Capital
Ontario, Canada
$56K -$13.9K -27,262 -21%
Hudson Bay Capital Management
14
Hudson Bay Capital Management
Connecticut
$49K +$46.3K +90,962 New
CAC
15
Cowen and Company
New York
$43K +$315 +619 +0.8%
Walleye Trading
16
Walleye Trading
New York
$31K
PCM
17
Prelude Capital Management
New York
$8K +$7.63K +15,000 New
Susquehanna International Group
18
Susquehanna International Group
Pennsylvania
$6K +$5.79K +11,382 New
UBS Group
19
UBS Group
Switzerland
$4K +$284 +559 +8%
Walleye Capital
20
Walleye Capital
New York
$47
KJHP
21
K.J. Harrison & Partners
Ontario, Canada
$8
ES
22
Equitec Specialists
Illinois
-$15K -34,180 Closed
VF
23
Virtu Financial
New York
-$5K -10,761 Closed

COEPW Hedge Fund Activity: Q2 2021 in Review

21 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Coeptis Therapeutics Warrants (COEPW) for Q2 2021, worth a combined $2.82M — up 59% from $1.77M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new COEPW positions and 2 closed out — a net gain of 4 holders — while 2 added to existing stakes and 2 trimmed.

The largest buyer was Glazer Capital LLC, opening a new position worth an estimated $454K. The largest seller was Equitec Specialists, exiting entirely with an estimated $15K sold.

  • 21 institutional investors held Coeptis Therapeutics Warrants (COEPW) as of Q2 2021, up from 17 in Q1 2021.
  • Funds reported $2.82M of Coeptis Therapeutics Warrants stock for Q2 2021, up 59% quarter-over-quarter.
  • 6 funds opened new Coeptis Therapeutics Warrants positions in Q2 2021 and 2 closed out, a net change of +4 holders.
  • The largest Coeptis Therapeutics Warrants buyer in Q2 2021 was Glazer Capital LLC, an estimated $454K added.
  • The largest Coeptis Therapeutics Warrants seller in Q2 2021 was Equitec Specialists, an estimated $15K sold.

Based on aggregated 13F filings for Q2 2021.